Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999-2014
- PMID: 27607541
- PMCID: PMC5122483
- DOI: 10.1513/AnnalsATS.201606-474BC
Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999-2014
Abstract
Rationale: Unlike tuberculosis, nontuberculous mycobacterial disease is not reportable to public health authorities in the United States, and the total burden of disease is uncertain.
Objectives: To estimate the mortality of nontuberculous mycobacterial disease in the United States over a 15-year period and to identify temporal trends.
Methods: The U.S. Multiple Cause of Death Files from 1999 through 2014 were searched for a listing of nontuberculous mycobacterial disease by International Classification of Diseases, Tenth Revision code as either the underlying or a contributing cause of death. Characteristics of individuals with nontuberculous mycobacteria-related deaths in the United States were summarized according to demographic characteristics. Age-adjusted mortality rates and rate ratios were calculated using bridged-race population estimates of U.S. census population data. Time trends were evaluated with negative binomial regression.
Measurements and main results: There was a significant increase in nontuberculous mycobacteria-related deaths among individuals without a diagnosis of HIV infection (P = 0.004). Mortality rates increased with advancing age. Age-adjusted mortality rate ratios were lower for men (risk ratio [RR], 0.84; 95% confidence interval [CI], 0.80-0.87) compared with women, and were lower for Hispanic individuals (RR, 0.53; 95% CI, 0.49-0.56) and black, non-Hispanic persons (RR, 0.83; 95% CI, 0.77-0.88) compared with white, non-Hispanic individuals.
Conclusions: The mortality rate of nontuberculous mycobacterial disease among HIV-uninfected individuals has increased in the United States between 1999 and 2014. These deaths occurred disproportionately in older white women. Considering the concurrent decline in tuberculosis-related deaths, these findings demonstrate a shift in the epidemiology of fatal mycobacterial infections in the United States.
Keywords: epidemiology; mortality; nontuberculous mycobacteria.
Figures


Similar articles
-
The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.Ann Am Thorac Soc. 2015 Oct;12(10):1458-64. doi: 10.1513/AnnalsATS.201503-173OC. Ann Am Thorac Soc. 2015. PMID: 26214350 Free PMC article.
-
Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.PLoS One. 2014 Mar 14;9(3):e91879. doi: 10.1371/journal.pone.0091879. eCollection 2014. PLoS One. 2014. PMID: 24632814 Free PMC article.
-
Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009-2013.Ann Am Thorac Soc. 2017 Nov;14(11):1655-1661. doi: 10.1513/AnnalsATS.201611-860OC. Ann Am Thorac Soc. 2017. PMID: 28817307 Free PMC article.
-
Mycobacterial Infections Potentiated by Biologics.Infect Dis Clin North Am. 2020 Jun;34(2):413-423. doi: 10.1016/j.idc.2020.02.011. Infect Dis Clin North Am. 2020. PMID: 32444014 Review.
-
Increasing mortality from pulmonary embolism in Japan, 1951-2000.Circ J. 2002 Dec;66(12):1144-9. doi: 10.1253/circj.66.1144. Circ J. 2002. PMID: 12499622 Review.
Cited by
-
Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease.Clin Infect Dis. 2021 May 18;72(10):e552-e557. doi: 10.1093/cid/ciaa1267. Clin Infect Dis. 2021. PMID: 32856690 Free PMC article.
-
ERS International Congress 2022: highlights from the Respiratory Infections Assembly.ERJ Open Res. 2023 May 22;9(3):00628-2022. doi: 10.1183/23120541.00628-2022. eCollection 2023 May. ERJ Open Res. 2023. PMID: 37228292 Free PMC article.
-
Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population.Respir Med. 2018 Dec;145:80-88. doi: 10.1016/j.rmed.2018.10.022. Epub 2018 Oct 22. Respir Med. 2018. PMID: 30509721 Free PMC article.
-
Epidemiology of Nontuberculous Mycobacteriosis.Semin Respir Crit Care Med. 2018 Jun;39(3):325-335. doi: 10.1055/s-0038-1651491. Epub 2018 Aug 2. Semin Respir Crit Care Med. 2018. PMID: 30071547 Free PMC article. Review.
-
Health Care Utilization and Expenditures Following Diagnosis of Nontuberculous Mycobacterial Lung Disease in the United States.J Manag Care Spec Pharm. 2018 Oct;24(10):964-974. doi: 10.18553/jmcp.2018.18122. Epub 2018 Jul 20. J Manag Care Spec Pharm. 2018. PMID: 30028225 Free PMC article.
References
-
- Falkinham JO., III Current epidemiologic trends of the nontuberculous mycobacteria (NTM) Curr Environ Health Rep. 2016;3:161–167. - PubMed
-
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al. ATS Mycobacterial Diseases Subcommittee American Thoracic Society Infectious Disease Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 2007175367–416.[Published erratum appears in Am J Respir Crit Care Med 175:744–745.] - PubMed
-
- Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis. 2004;4:557–565. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical